tiprankstipranks
Advertisement
Advertisement

ALXO Stock Latest News

Analyst Reiterates Buy on ALX Oncology, Maintains $6 Price Target on De-Risked CD47 Program and Upcoming Catalysts
RatingsAnalyst Reiterates Buy on ALX Oncology, Maintains $6 Price Target on De-Risked CD47 Program and Upcoming Catalysts
9d ago
ALXO
Alx Oncology Signals Promise, But Validation Looms
PremiumCompany Announcements
Alx Oncology Signals Promise, But Validation Looms
9d ago
ALXO
Analyst Reiterates Buy on Evorpacept’s Biomarker-Driven Potential, Maintains $4 Price Target
PremiumRatings
Analyst Reiterates Buy on Evorpacept’s Biomarker-Driven Potential, Maintains $4 Price Target
10d ago
ALXO
ALX Oncology evorpacept combination data presented at ESMO congress
PremiumThe Fly
ALX Oncology evorpacept combination data presented at ESMO congress
13d ago
ALXO
JAZZ
Is ALXO a Buy, Before Earnings?
PremiumPre-Earnings
Is ALXO a Buy, Before Earnings?
15d ago
ALXO
ALX Oncology appoints Jeff Knight as chief development, operating officer
PremiumThe FlyALX Oncology appoints Jeff Knight as chief development, operating officer
1M ago
ALXO
CRNX
ALX Oncology Appoints Jeff Knight to Lead Development
Premium
Company Announcements
ALX Oncology Appoints Jeff Knight to Lead Development
1M ago
8K
ALXO
ALX Oncology initiated with an Overweight at Wells Fargo
Premium
The Fly
ALX Oncology initiated with an Overweight at Wells Fargo
2M ago
ALXO
Alx Oncology Faces Renewed Nasdaq Listing Risk After Prior Minimum Bid Price Violation
PremiumCompany Announcements
Alx Oncology Faces Renewed Nasdaq Listing Risk After Prior Minimum Bid Price Violation
2M ago
ALXO
ALX Oncology price target raised to $4 from $2 at H.C. Wainwright
PremiumThe Fly
ALX Oncology price target raised to $4 from $2 at H.C. Wainwright
2M ago
ALXO
Alx Oncology Earnings Call Highlights Biomarker Momentum
PremiumCompany Announcements
Alx Oncology Earnings Call Highlights Biomarker Momentum
2M ago
ALXO
ALX Oncology initiated with a Buy at UBS
PremiumThe Fly
ALX Oncology initiated with a Buy at UBS
3M ago
ALXO
ALX Oncology reports Q4 EPS (42c), consensus (36c)
PremiumThe FlyALX Oncology reports Q4 EPS (42c), consensus (36c)
3M ago
ALXO
ALXO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ALXO Earnings this Week: How Will it Perform?
3M ago
ALXO
ALX Oncology price target raised to $4 from $3 at Piper Sandler
Premium
The Fly
ALX Oncology price target raised to $4 from $3 at Piper Sandler
3M ago
ALXO
ALX Oncology announces major underwritten public equity offering
PremiumCompany Announcements
ALX Oncology announces major underwritten public equity offering
4M ago
8K
ALXO
ALX Oncology Highlights Biomarker Data and Cash Position
PremiumCompany Announcements
ALX Oncology Highlights Biomarker Data and Cash Position
4M ago
8K
ALXO
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
PremiumThe Fly
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
4M ago
ALXO
JAZZ
ALX Oncology Expands Inducement Equity Plan for Hiring
PremiumCompany Announcements
ALX Oncology Expands Inducement Equity Plan for Hiring
4M ago
8K
ALXO
ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial
PremiumThe FlyALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial
4M ago
ALXO
ALX Oncology announces data from Phase 2 trial of evorpacept
Premium
The Fly
ALX Oncology announces data from Phase 2 trial of evorpacept
5M ago
ALXO
ALX Oncology initiated with a Buy at Jefferies
Premium
The Fly
ALX Oncology initiated with a Buy at Jefferies
6M ago
ALXO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >